Reducing Blood Testing in Pediatric Patients after Heart Surgery: Proving Sustainability

Stephanie A Bodily1, Claudia Delgado-Corcoran1, Katherine Wolpert1

  • 1Division of Pediatric Critical Care Medicine, Primary Children's Hospital, Intermountain Health Care, Salt Lake City, Utah; and Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Utah, Salt Lake City, Utah.

Pediatric Quality & Safety
|September 20, 2018
PubMed

Insights

A quality improvement initiative successfully reduced blood testing in pediatric cardiac surgery patients. This sustained reduction in laboratory tests may be linked to increased reintubation and arrhythmias in high-risk patients.

Area of Science:

  • Pediatric Cardiac Surgery
  • Quality Improvement in Healthcare
  • Intensive Care Medicine

Background:

  • Frequent blood testing in pediatric intensive care units poses risks such as iatrogenic anemia and infection.
  • A quality improvement (QI) initiative was implemented in 2011 to reduce routine blood testing.

Purpose of the Study:

  • To describe the sustained reduction in blood testing over three years following a QI initiative.
  • To evaluate the impact of reduced blood testing on patient safety and adverse outcomes in post-operative pediatric cardiac surgery patients.

Main Methods:

  • A cohort of post-operative pediatric cardiac surgery patients (N=1169) were studied across preintervention (2010), intervention (2011), and postintervention (2012-13) periods.
  • The QI initiative replaced standing laboratory orders with condition-based testing.
  • Data collected included laboratory studies per patient (labs/pt), labs per patient per day (labs/pt/d), and adverse outcomes (reintubation, infections, mortality).

Main Results:

  • Sustained reduction in labs/pt (38 to 23) and labs/pt/d (15 to 10) was observed post-QI implementation.
  • The postintervention group exhibited higher surgical complexity (RACHS 3-4), younger age, and smaller size.
  • Increased risk of reintubation and arrhythmias was noted in children with RACHS 3-4 classification postintervention.

Conclusions:

  • A QI initiative effectively reduced and sustained lower blood testing rates in young, complex pediatric cardiac surgery patients.
  • The study suggests a potential association between reduced blood testing and increased reintubation and arrhythmias in high-risk (RACHS 3-4) patients, warranting further investigation.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
264
Sustainable Development01:43

Sustainable Development

As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
15.1K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
311
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
233
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
301
Anatomy of the Heart01:27

Anatomy of the Heart

The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
119.9K